Post-Infection Zika Virus Shed in Saliva and Semen
|
By LabMedica International staff writers Posted on 19 Oct 2016 |

Image: Digitally colorized transmission electron micrograph (TEM) of Zika virus. Virus particles, colored red, are 40 nanometers in diameter, with an outer envelope, and an inner dense core (Photo courtesy of the CDC).
Results of a study of the mechanism of Zika virus infection in two primate models demonstrated that the virus spread rapidly into the nervous system of healthy animals and that shedding of the virus in saliva and semen underscored possible concern for additional neurological complications and non-mosquito-mediated transmission in humans.
Infection with Zika virus has been associated with serious neurological complications and fetal abnormalities. However, the dynamics of viral infection, replication and shedding are poorly understood.
To obtain a better understanding of the mechanism that underlies Zika virus infection, investigators at Beth Israel Deaconess Medical Center (Boston, MA, USA) colleagues infected 36 rhesus and cynomolgus macaques with subcutaneous injections of strains of the Zika virus from Puerto Rico and Thailand. Over the next four weeks, the investigators analyzed blood, tissues, cerebrospinal fluid (CSF), and mucosal secretions for the presence of Zika virus RNA and monitored the animals' immune response during early infection.
They reported in the October 3, 2016, online edition of the journal Nature Medicine that viral RNA could be detected in blood plasma as early as one day after infection. Viral RNA was also detected in saliva, urine, CSF, and semen, but only transiently in vaginal secretions. Although viral RNA during primary infection was cleared from blood plasma and urine within 10 days, viral RNA was detectable in saliva and seminal fluids until the end of the study, three weeks after the disappearance of viral RNA from the blood. Zika RNA was also identified in tissues, including the brain and male and female reproductive tissues, during early and late stages of infection.
The control of primary Zika virus infection in the blood was correlated with rapid innate and adaptive immune responses. Re-infection of six animals 45 days after primary infection with a heterologous strain of the virus resulted in complete protection, which suggested that primary Zika virus infection elicited protective immunity.
“We found, initially, that the virus replicated very rapidly and was cleared from the blood in most animals within ten days,” said senior author Dr. James B. Whitney, assistant professor of medicine at Beth Israel Deaconess Medical Center. “Nevertheless, we observed viral shedding in other bodily fluids such as spinal fluid, saliva, urine, and semen up to three weeks after the initial infection was already cleared. Of particular concern, we saw extraordinarily high levels of Zika virus in the brain of some of the animals – the cerebellum, specifically – soon after infection. Only one in five adults have noticeable symptoms of infection. However, if our data translate to humans, there may be need for enhanced clinical vigilance for any persons presenting with unusual neurological symptoms, and they should be tested for Zika infection.”
“We found that male-to-female transmission might be easier, while female-to-male may be less likely,” said Dr. Whitney. “Nonetheless, the high levels of Zika we observed in the uterus underscore the danger to a developing fetus.”
Related Links:
Beth Israel Deaconess Medical Center
Infection with Zika virus has been associated with serious neurological complications and fetal abnormalities. However, the dynamics of viral infection, replication and shedding are poorly understood.
To obtain a better understanding of the mechanism that underlies Zika virus infection, investigators at Beth Israel Deaconess Medical Center (Boston, MA, USA) colleagues infected 36 rhesus and cynomolgus macaques with subcutaneous injections of strains of the Zika virus from Puerto Rico and Thailand. Over the next four weeks, the investigators analyzed blood, tissues, cerebrospinal fluid (CSF), and mucosal secretions for the presence of Zika virus RNA and monitored the animals' immune response during early infection.
They reported in the October 3, 2016, online edition of the journal Nature Medicine that viral RNA could be detected in blood plasma as early as one day after infection. Viral RNA was also detected in saliva, urine, CSF, and semen, but only transiently in vaginal secretions. Although viral RNA during primary infection was cleared from blood plasma and urine within 10 days, viral RNA was detectable in saliva and seminal fluids until the end of the study, three weeks after the disappearance of viral RNA from the blood. Zika RNA was also identified in tissues, including the brain and male and female reproductive tissues, during early and late stages of infection.
The control of primary Zika virus infection in the blood was correlated with rapid innate and adaptive immune responses. Re-infection of six animals 45 days after primary infection with a heterologous strain of the virus resulted in complete protection, which suggested that primary Zika virus infection elicited protective immunity.
“We found, initially, that the virus replicated very rapidly and was cleared from the blood in most animals within ten days,” said senior author Dr. James B. Whitney, assistant professor of medicine at Beth Israel Deaconess Medical Center. “Nevertheless, we observed viral shedding in other bodily fluids such as spinal fluid, saliva, urine, and semen up to three weeks after the initial infection was already cleared. Of particular concern, we saw extraordinarily high levels of Zika virus in the brain of some of the animals – the cerebellum, specifically – soon after infection. Only one in five adults have noticeable symptoms of infection. However, if our data translate to humans, there may be need for enhanced clinical vigilance for any persons presenting with unusual neurological symptoms, and they should be tested for Zika infection.”
“We found that male-to-female transmission might be easier, while female-to-male may be less likely,” said Dr. Whitney. “Nonetheless, the high levels of Zika we observed in the uterus underscore the danger to a developing fetus.”
Related Links:
Beth Israel Deaconess Medical Center
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







